Advertisement
International
Subscribe to International

The Lead

EMA Provides Update on Stolen Vials of Herceptin

April 18, 2014 8:26 am | News | Comments

Italian law enforcement authorities are currently investing the theft. However, the situation goes beyond EU and national current practices for handling quality or product defects; these are extraordinary circumstances driven by criminal activities that require special measures and strong collaboration from authorities across the EU.

Servier, Lab Founder in Drug Scandal, Dies at 92

April 17, 2014 8:07 am | News | Comments

Jacques Servier, the founder of France's second-largest pharmaceutical group who became ensnared...

EMA Reports Vials of Falsified Herceptin Identified

April 16, 2014 8:41 am | News | Comments

The European Medicines Agency (EMA) has been informed that vials of the cancer medicine...

BioAlliance Pharma and Topotarget Announce Merger Agreement

April 16, 2014 8:22 am | News | Comments

BioAlliance Pharma SA and Topotarget A/S today announced their intention to merge to create an...

View Sample

FREE Email Newsletter

Report: Glaxo Bribed Doctors in Poland

April 14, 2014 9:25 am | News | Comments

The BBC reports that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to prescribe medicines in Poland. A "Panorama" show to air Monday evening quotes a former sales representative for the company saying doctors there were paid to prescribe its drugs.

Moberg Pharma Acquires Rights to Topical Formulation for Treatment of Oral Pain

April 14, 2014 7:58 am | News | Comments

Moberg Pharma AB has entered into a definitive agreement with Oracain II Aps (Denmark) to acquire all assets and global rights to a novel and patent pending oral formulation of the proven substance bupivacaine, for the treatment of pain in the oral cavity.

Ranbaxy: Lessons and Opportunities

April 10, 2014 8:48 am | by Girish Malhotra, President, EPCOT International | Blogs | Comments

Will Sun’s latest acquisition change the global pharma landscape, or result in yet another problem-filled “me too” pharma company?                    

Advertisement

Oramed Granted Patent in Hong Kong for Oral Administration of Insulin

April 10, 2014 8:16 am | News | Comments

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems,  announced today that the Intellectual Property Department of Hong Kong  has granted the Company's patent for its invention, titled "Methods  and Compositions for Oral Administrations of Proteins."

Meda Turns Down Mylan

April 4, 2014 10:57 am | News | Comments

Swedish drug company Meda has rebuffed an approach from generic drug maker Mylan which was looking to combine the two businesses. Meda AB says talks between the two companies have stopped "without further actions."          

Gilead Announces Results From Phase II Study of Sofosbuvir Among Hepatitis C Patients in Japan

April 3, 2014 8:22 am | News | Comments

Gilead Sciences has announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.

Actavis Opens Asia Pacific Regional Headquarters in Singapore

April 3, 2014 8:09 am | News | Comments

Actavis has announced the official opening of its new regional office in Singapore that will serve as the headquarters for the company's Asia Pacific and Africa (APACA) region.             

Novartis Top Management Quits Over Involvement in Clinical Study

April 3, 2014 8:04 am | News | Comments

Novartis Pharma K.K. said Thursday its president Yoshiyasu Ninomiya and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.     

Advertisement

FDA OKs First Hay Fever Allergy Immunotherapy Tablet

April 2, 2014 11:28 am | by The Associated Press | News | Comments

The U.S. Food and Drug Administration has approved the first tablet for gradually reducing hay fever allergy symptoms, an alternative to uncomfortable allergy-desensitizing shots.            

Evotec and Debiopharm Group to Develop Cancer Treatment

April 2, 2014 8:47 am | News | Comments

Evotec AG has announced a research collaboration and licensing deal with Debiopharm Group Lausanne, Switzerland. The objective of this collaboration is to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemias with defined genetic alterations.

Actavis Acquires Silom Medical Company

April 1, 2014 8:56 am | News | Comments

Actavis today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.      

Evotec and Convergence Form Integrated Pain Alliance

March 31, 2014 9:02 am | News | Comments

Evotec AG today announced that it has entered into a research alliance with Panion Ltd, a subsidiary of Convergence Pharmaceuticals Holdings Ltd. Convergence is a UK company focused on the development of novel, high value analgesics to treat chronic pain.

Britain: Two People Catch TB from Pet Cat

March 28, 2014 8:18 am | News | Comments

England's public health agency says two people have caught tuberculosis from a pet cat, the first time the bacterial disease has been documented to spread from cat to human.             

Advertisement

XTANDI Capsules Approved in Japan for Prostate Cancer

March 25, 2014 7:20 am | News | Comments

Astellas Pharma Inc. has obtained marketing approval of their oral androgen receptor signaling inhibitor, XTANDI capsules 40mg  for the treatment of patients with castration-resistant prostate cancer in Japan.      

Japan Approves Forxiga® for Type 2 Diabetes

March 24, 2014 9:00 am | News | Comments

AstraZeneca today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved FORXIGA® (dapagliflozin in 5 and 10 mg tablets), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, as a once-daily oral treatment for type 2 diabetes.

Will India Soon be Free from Polio?

March 24, 2014 8:54 am | Videos | Comments

A polio-free India is one of the biggest global public health achievements of recent times.                           

Endocyte Surges on News for Cancer Drug

March 24, 2014 8:16 am | News | Comments

Shares of Endocyte nearly doubled in value Friday after European Union regulators said the company's drug Vynfinit should be approved as a treatment for ovarian cancer.              

Samsca® Approved in Japan as World's First Drug Therapy for ADPKD, a Rare Kidney Disease

March 24, 2014 8:05 am | News | Comments

Otsuka Pharmaceutical Co. has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD).           

U.S. Pharmaceutical Company to Move HQ to Ireland

March 21, 2014 8:32 am | Videos | Comments

Horizon Pharma Inc. will acquire Vidara Therapeutics for a "tax-efficient corporate structure."                          

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences

March 14, 2014 8:38 am | News | Comments

Idenix Pharmaceuticals has filed patent infringement lawsuits against Gilead Sciences and/or certain of its subsidiaries in each of three countries - France, Germany and the United Kingdom.           

Intrexon Acquires Lab Operations from Codexis

March 14, 2014 8:09 am | News | Comments

Intrexon Corporation, a synthetic biology company,  has acquired state-of-the-art laboratory operations in Budapest, Hungary from Codexis, Inc., a developer of biocatalysts for the pharmaceutical and complex chemistry industries.    

Applikon Biotechnology to Open New Facility in Guangzhou, China

March 13, 2014 11:20 am | News | Comments

Applikon Biotechnology will open a new production facility on Wednesday March 19th in Guangzhou, China. The opening ceremony will be combined with a scientific seminar “Innovations in bioreactor technology”.        

Chiesi Group Reports Double-Digit Growth and International Expansion

March 13, 2014 8:04 am | News | Comments

Chiesi Farmaceutici SpA, an international pharmaceutical company focused in the respiratory, neonatology and special care therapeutic areas, closed 2013 with a turnover of more than 1,236 million euro, an increase of 11.8% compared to 2012 (+14% at constant exchange rates).

AstraZeneca to Sell Alderley Park Site in Cheshire, UK

March 12, 2014 8:03 am | News | Comments

AstraZeneca today announced the sale of its Alderley Park site in Cheshire, UK, to Manchester Science Parks (MSP), a Greater Manchester based public-private partnership and science park operator.         

Clinipace Worldwide Acquires Choice Pharma - Expands into Asia

March 11, 2014 11:09 am | News | Comments

With the merger, the company extends its global footprint to include 20 operational offices in 15 countries, including new offices in Taiwan, China, Hong Kong, South Korea, Vietnam, Singapore, and Malaysia.       

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading